From: Development and pilot testing of a decision aid for navigating breast cancer survivorship care
Characteristic | Round 1 | Round 2 | Round 3 |
---|---|---|---|
Breast cancer survivors | n = 5 | n = 5 | n = 5 |
Age, median (range) | 51 (46–54) | 49 (47–64) | 60 (47–67) |
Race, n (%) | |||
 Chinese | 4 (80%) | 4 (80%) | 3 (60%) |
 Malay | 1 (20%) | 0 | 2 (40%) |
 Others | 0 | 1a (20%) | 0 |
Education level, n (%) | |||
 Secondary | 1 (20%) | 1 (20%) | 1 (20%) |
 Pre-university | 1 (20%) | 1 (20%) | 2 (40%) |
 Graduate/postgraduate | 3 (60%) | 3 (60%) | 2 (40%) |
 Survivorship years since diagnosis, median (range) | 9 (8–12) | 8 (8–10) | 7 (10–13) |
Breast cancer stageb, n (%) | |||
 1 | 1 (20%) | 3 (60%) | 1 (20%) |
 2 | 2 (40%) | 2 (40%) | 2 (40%) |
 3 | 1 (20%) | 0 | 2 (40%) |
Treatment modality, n (%) | |||
 Surgery | 5 (100%) | 5 (100%) | 5 (100%) |
 Chemotherapy | 5 (100%) | 5 (100%) | 4 (80%) |
 Radiotherapy | 5 (100%) | 3 (60%) | 4 (80%) |
 Endocrine therapy | 3 (60%) | 3 (60%) | 3 (60%) |
Health care professionals | n = 3 | n = 3 | n = 2 |
---|---|---|---|
Discipline, n (%) | |||
 Medical oncology | 2 (67%) | 0 | 1 (50%) |
 Radiation oncology | 0 | 1 (33%) | 0 |
 Surgical oncology | 0 | 2 (67%) | 0 |
 Nursing | 0 | 0 | 1 (50%) |
 Pharmacy | 1 (33.3%) | 0 | 0 |
Years of practice, n (%) | |||
 10–20 years | 2 (67%) | 3 (100%) | 2 (100%) |
 > 20 years | 1 (33%) | 0 | 0 |